Het volume van chirurgische ingrepen en de impact ervan op ... - KCE
Het volume van chirurgische ingrepen en de impact ervan op ... - KCE
Het volume van chirurgische ingrepen en de impact ervan op ... - KCE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>KCE</strong> Reports 113 Volume Outcome 101<br />
5.5.3.2 Linkage with data from IMA and BCR<br />
The Minimal Clinical Data (MCD) data were linked with the Common Sickness Funds<br />
Ag<strong>en</strong>cy (IMA) database and the Belgian Cancer Registry (BCR) database. Table 5.51<br />
shows that 98.1% of 9 633 MCD stays could be linked with IMA data and 87.4% with<br />
BCR data (on the basis of ICD-10 co<strong>de</strong>s C50 and D05). Information on tumour stage<br />
could be retrieved for 79.3% of 9 633 MCD stays.<br />
Table 5.51: Breast cancer surgery: Perc<strong>en</strong>tage of linkage of MCD data with<br />
data from IMA and BCR<br />
Number %<br />
Number of stays in MCD selection 9 633<br />
Linkage with IMA 9 450 98.10<br />
Linkage with BCR 8 416 87.37<br />
Linkage with BCR and data about stage 7 643 79.34<br />
Results of linkage: 8 416 pati<strong>en</strong>ts with breast cancer surgery could be linked<br />
with Belgian Cancer Registry data. For 7 643 of these pati<strong>en</strong>ts, the BCR<br />
contained information on the stage of the tumour.<br />
5.5.3.3 Pati<strong>en</strong>t and tumour characteristics<br />
Tumour location is <strong>de</strong>fined according to ICD-10 co<strong>de</strong>:<br />
• C50 for malignant ne<strong>op</strong>lasm of breast<br />
• D05 for carcinoma in situ of breast.<br />
Tumour histology is not used as a variable for risk adjustm<strong>en</strong>t and is therefore not<br />
analyzed in this section. Instead, however, several authors used the tumour<br />
differ<strong>en</strong>tiation (also known as gra<strong>de</strong>) for risk adjustm<strong>en</strong>t: 221-223<br />
• Gra<strong>de</strong> I : well differ<strong>en</strong>tiated<br />
• Gra<strong>de</strong> II : mo<strong>de</strong>rately differ<strong>en</strong>tiated<br />
• Gra<strong>de</strong> III : poorly differ<strong>en</strong>tiated<br />
• Gra<strong>de</strong> IV : undiffer<strong>en</strong>tiated<br />
• Unknown differ<strong>en</strong>tiation.<br />
For a <strong>de</strong>tailed <strong>de</strong>scription of TNM classification and TNM stages for breast cancer, we<br />
224, 225<br />
refer to <strong>KCE</strong> report 63.<br />
Table 5.52 shows that the mean age of the 9 633 pati<strong>en</strong>ts selected in the MCD was 60.1<br />
years. Median age is 60.0 years. Carcinoma in situ repres<strong>en</strong>ts only 8.5% of all pati<strong>en</strong>ts<br />
<strong>op</strong>erated for breast cancer. Gra<strong>de</strong> II and III are the most repres<strong>en</strong>ted (34% and 32%,<br />
respectively). 41% of the <strong>op</strong>erated pati<strong>en</strong>ts have gra<strong>de</strong> 1 breast cancer. Stage 2 disease<br />
comes second with 37.8%.